Chinese herbal medicines: The modulator of nonalcoholic fatty liver disease targeting oxidative stress

P Gong, H Long, Y Guo, Z Wang, W Yao, J Wang… - Journal of …, 2024 - Elsevier
Ethnopharmacological relevance Plants are a natural treasure trove; their secondary
metabolites participate in several pharmacological processes, making them a crucial …

Resveratrol for the management of human health: how far have we come? A systematic review of resveratrol clinical trials to highlight gaps and opportunities

K Brown, D Theofanous, RG Britton, G Aburido… - International Journal of …, 2024 - mdpi.com
Resveratrol has long been proposed as being beneficial to human health across multiple
morbidities, yet there is currently no conclusive clinical evidence to advocate its …

The Role of Antioxidants in the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review

K Mohammadian, F Fakhar, S Keramat, A Stanek - Antioxidants, 2024 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is a global public health problem that causes liver-
related morbidity and mortality. It is also an independent risk factor for non-communicable …

Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)?

K Kasprzak-Drozd, P Niziński, P Kasprzak… - International Journal of …, 2024 - mdpi.com
Metabolic dysfunction-associated steatotic liver disease (MASLD) is influenced by a variety
of factors, including environmental and genetic factors. The most significant outcome is the …

The effect of soy isoflavones on non-alcoholic fatty liver disease and the level of fibroblast growth factor-21 and fetuin A

A Neshatbini Tehrani, B Hatami, B Helli, Z Yari… - Scientific Reports, 2024 - nature.com
A two-arm randomized open labeled controlled clinical trial was conducted on 50 patients
with non-alcoholic fatty liver disease (NAFLD). Subjects were randomized to either receive …

[HTML][HTML] Evidence-based herbal treatments in liver diseases

M Mancak, D Altintas, Y Balaban, UK Caliskan - Hepatology forum, 2024 - ncbi.nlm.nih.gov
The liver is the main organ for metabolic and detoxification reactions in the body. Therefore,
its diseases can be associated with both metabolic disorders, such as insulin resistance …

[HTML][HTML] Decreasing the Burden of Non-Alcoholic Fatty Liver Disease: from Therapeutic Targets to Drug Discovery Opportunities

R Amorim, P Soares, D Chavarria, S Benfeito… - European Journal of …, 2024 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) presents a pervasive global pandemic, affecting
approximately 25% of the world's population. This grave health issue not only demands …

The effect of soy isoflavones supplementation on metabolic status in patients with non-alcoholic fatty liver disease: a randomized placebo controlled clinical trial

A Neshatbini Tehrani, B Hatami, G Daftari… - BMC Public Health, 2024 - Springer
Background Non-alcoholic fatty liver disease (NAFLD) accounts as a crucial health concern
with a huge burden on health and economic systems. The aim of this study is to evaluate the …

[HTML][HTML] SIRT1: Harnessing multiple pathways to hinder NAFLD

C Tian, R Huang, M Xiang - Pharmacological Research, 2024 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) encompasses hepatic steatosis, non-alcoholic
steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular carcinoma. It is the primary …

Effects of different natural products in patients with non‐alcoholic fatty liver disease—A network meta‐analysis of randomized controlled trials

H Liu, Y Li, Y Jin, X Li, D Wang, X Yu… - Phytotherapy …, 2024 - Wiley Online Library
Due to a scarcity of appropriate therapeutic approaches capable of ameliorating or
eliminating non‐alcoholic fatty liver disease (NAFLD), many researchers have come to focus …